Fong T M, Yu H, Cascieri M A, Underwood D, Swain C J, Strader C D
Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065.
J Biol Chem. 1994 Jan 28;269(4):2728-32.
Previous studies suggested that the antagonist binding site in the neurokinin-1 receptor is composed of phylogenetically conserved residues, while phylogenetically divergent residues affect the conformation of the binding site. To test this hypothesis, we investigated the role of conserved residues in antagonist binding. Histidine 197 in the human receptor was found to interact with CP-96,345 but not RP67580. In addition, a nearby residue, histidine 265 of the human receptor, is required for the binding of RP67580 but not CP-96,345 or substance P. The interaction between residue 265 and RP67580 is consistent with a hydrogen bonding interaction. Analysis of several analogs of CP-96,345 revealed that histidine 265 of the human receptor is in proximity to the substituted benzyl moiety of CP-96,345, and can interact with other analogs of CP-96,345. In contrast to the human neurokinin-1 receptor, both histidine 197 and histidine 265 in the rat neurokinin-1 receptor appear to interact with both CP-96,345 and RP67580. These results support a conformational difference between the antagonist binding sites of the rat and human neurokinin-1 receptors and provide a model for examining specific interactions between antagonists and the receptor.
先前的研究表明,神经激肽-1受体中的拮抗剂结合位点由系统发育保守的残基组成,而系统发育上不同的残基会影响结合位点的构象。为了验证这一假设,我们研究了保守残基在拮抗剂结合中的作用。发现人类受体中的组氨酸197与CP-96,345相互作用,但不与RP67580相互作用。此外,人类受体中一个附近的残基,即组氨酸265,是RP67580结合所必需的,但不是CP-96,345或P物质结合所必需的。残基265与RP67580之间的相互作用与氢键相互作用一致。对CP-96,345的几种类似物的分析表明,人类受体中的组氨酸265靠近CP-96,345的取代苄基部分,并且可以与CP-96,345的其他类似物相互作用。与人类神经激肽-1受体不同,大鼠神经激肽-1受体中的组氨酸197和组氨酸265似乎都与CP-96,345和RP67580相互作用。这些结果支持大鼠和人类神经激肽-1受体拮抗剂结合位点之间的构象差异,并为研究拮抗剂与受体之间的特异性相互作用提供了一个模型。